Prostate International
Scope & Guideline
Leading the charge in prostate health research and innovation.
Introduction
Aims and Scopes
- Prostate Cancer Research:
The journal emphasizes comprehensive studies on prostate cancer, including diagnosis, treatment modalities, outcomes, and survivorship. It covers both surgical and medical management approaches. - Benign Prostatic Hyperplasia (BPH) Studies:
Research on BPH is a core focus, exploring its management, treatment options, and the impact of lifestyle factors on disease progression. - Innovative Diagnostic Techniques:
The journal highlights advancements in diagnostic methodologies, such as MRI, biopsy techniques, and biomarker research, that facilitate better detection and management of prostate diseases. - Surgical Techniques and Outcomes:
Research on various surgical approaches, including robotic-assisted surgery and minimally invasive techniques, is extensively covered, analyzing their efficacy and safety. - Patient-Centered Outcomes:
The journal prioritizes studies assessing quality of life and functional outcomes related to prostate diseases, ensuring that patient perspectives are integral to clinical research. - Interdisciplinary Approaches:
Prostate International encourages collaboration across specialties, integrating urology, oncology, radiology, and pathology to provide a holistic view of prostate health.
Trending and Emerging
- Biomarkers and Genetic Profiling:
There is a rising trend in the investigation of biomarkers and genetic markers that can predict prostate cancer risk and treatment responses, emphasizing personalized medicine. - Minimally Invasive Techniques:
Studies on minimally invasive surgical techniques, including robotic-assisted surgeries and novel ablation methods, are increasingly prevalent, reflecting a shift towards reducing patient recovery times and complications. - Psychosocial Impact of Prostate Diseases:
Research exploring the psychosocial aspects of prostate diseases, including mental health implications and quality of life assessments, is gaining traction, underscoring the importance of holistic patient care. - Immunotherapy and Novel Agents:
Emerging studies focusing on immunotherapy and novel androgen receptor-targeted agents for prostate cancer treatment indicate a shift towards innovative therapeutic strategies. - Integration of Artificial Intelligence in Diagnostics:
The use of artificial intelligence in enhancing diagnostic accuracy and treatment planning is increasingly being explored, showcasing a significant trend towards technological integration in urology.
Declining or Waning
- Traditional Diagnostic Methods:
There is a noticeable decline in studies focusing on conventional biopsy techniques as newer imaging and diagnostic modalities, such as MRI-targeted biopsies, gain prominence. - Basic Science Research:
Research centered on the molecular and genetic underpinnings of prostate diseases appears to be waning, possibly due to a shift towards clinical applications and patient-centered studies. - Generalized Guidelines for Treatment:
The publication of broad treatment guidelines has decreased, indicating a shift towards more personalized and precision medicine approaches in prostate cancer management. - Longitudinal Studies of Older Treatments:
There is less emphasis on older treatment modalities, such as certain traditional surgical techniques or older pharmacological treatments, as newer options become available and are prioritized for research.
Similar Journals
Urology Journal
Driving progress in urology through shared knowledge.Urology Journal, published by the UROL & NEPHROL RES CTR-UNRC, is a pivotal open-access platform dedicated to advancing the field of urology since 2004. With a visible commitment to disseminating high-quality research, this journal plays a significant role in enhancing global knowledge and practices in urological health. With an impact factor reflective of its continuous growth, the journal has achieved a commendable position in the Scopus rankings, landing within the 46th percentile for urology. Operating out of Iran, the journal addresses a wide variety of topics pertinent to urological studies, making it invaluable for researchers, clinicians, and students in the field. The journal operates under the open-access model, ensuring that critical findings are available to a broader audience, thereby fostering collaboration and furthering education within the urology community. Whether you are keen on contemporary studies or emerging trends, Urology Journal serves as an essential resource for fostering academic dialogue and innovation in urology.
PROGRES EN UROLOGIE
Discovering Breakthroughs in UrologyPROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.
Urology Research and Practice
Unveiling cutting-edge discoveries in urology.Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.
Aging Male
Bridging research and clinical practice in male aging.Aging Male is an esteemed peer-reviewed journal published by Taylor & Francis Ltd, dedicated to the multidisciplinary field of geriatrics and gerontology. With an impressive impact factor, this journal ranks in the top quartile (Q2) of its categories, solidifying its reputation as a leading source of research and insights for professionals and academics in the field. Since transitioning to Open Access in 2021, Aging Male has broadened its reach, facilitating the dissemination of relevant research findings that address the complexities of aging in male populations globally. The journal accepts a wide range of contributions, including original research, reviews, and clinical studies, with particular emphasis on the biological, psychological, and social aspects of male aging. Researchers, clinicians, and students alike will find this journal an invaluable resource for advancing knowledge and practice in the dynamic landscape of geriatric medicine.
Advances in Urology
Pioneering Breakthroughs in Urological TreatmentAdvances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.
Journal of Clinical Urology
Empowering Urologists with Essential KnowledgeThe Journal of Clinical Urology, published by SAGE Publications Ltd, is a prominent academic platform dedicated to advancing the field of urology and surgical medicine. With an ISSN of 2051-4158 and an E-ISSN of 2051-4166, this journal has been pivotal in disseminating cutting-edge research since its inception in 2008 and is set to continue through 2024. Although categorized in the Q4 quartile for both Surgery and Urology, and positioned in the 24th and 22nd percentiles respectively according to Scopus rankings, the journal remains an essential resource for professionals, researchers, and students who seek to understand clinical developments and innovative practices in urological surgery. While the journal does not operate under an Open Access model, it provides critical insights and valuable findings that significantly impact healthcare practices and patient outcomes in the urology field.
Actas Urologicas Espanolas
Transforming Urological Care Through ResearchActas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.
PROSTATE CANCER AND PROSTATIC DISEASES
Connecting research and practice for prostate health.PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.
EUROPEAN UROLOGY
Leading the way in urological innovation and excellence.EUROPEAN UROLOGY is a prestigious journal in the field of urology, published by Elsevier, and residing in the vibrant academic landscape of the Netherlands. Since its inception in 1975, the journal has made significant contributions to urological research, earning a top rank of #1 out of 120 in the Scopus category of Medicine - Urology, placing it within the esteemed 99th percentile of its field. With a commitment to disseminating cutting-edge research, clinical findings, and innovative practices, EUROPEAN UROLOGY has established itself as a pivotal resource for urologists and researchers alike. Although it does not offer open access options, it provides an indispensable platform for scholarly communication that drives advancements in patient care and medical knowledge. As the journal embarks on converged years leading up to 2024, it continues to strive for excellence in urology, welcoming contributions that reflect the latest scientific advancements and clinical applications.
BJU INTERNATIONAL
Elevating Research, Transforming PracticeBJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.